Pharmacokinetic (PK) Analysis of Antitumor B in Patients With Oral Cancer

Medical College of Wisconsin
Active, not recruiting ID
For more information, see NCT03459729
A Window of Opportunity Clinical Trial. This study design permits examination of effects of an oral agent on cancer patients during the "window" between diagnosis of their cancer and their definitive cancer surgery. Similar to a phase 0 study, the trial design permits examination of the biologic effects of an agent; in this study pharmacokinetic properties will be examined.
Antitumor B
Squamous Cell Carcinoma of the Oral Cavity
Stuart Wong, MD

See list of participating sites